| 2024 | 2023 | |||
|---|---|---|---|---|
| Revenue | 97,1 k € | -18.8% | 119,6 k € | |
| Gross margin | -436,3 k € | -6.3% | -410,3 k € | |
| EBITDA | -544,1 k € | -32.5% | -410,6 k € | |
| Operating profit | -581,6 k € | -41.4% | -411,4 k € | |
| Profit/loss | -628,6 k € | -45.8% | -431,3 k € | |
| Equity | 194,7 k € | +145.4% | -429,3 k € | |
| Total assets | 2,7 M € | +643.5% | 359,2 k € | |
| Cash | 615,6 k € | +1610.5% | 36,0 k € | |
| Debts | 2,3 M € | +220.3% | 733,5 k € | |
| Staff | 1,8 | 0 | ||
Source: Belgian Official Gazette
Private limited company · Temse · incorporated on 16/12/2022 · 1,8 ETP
Private limited company loss-making in the latest fiscal year. Cash position rising (+1610.5%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Key indicators
C-Biotech is a Private limited company incorporated in 2022. Its main activity is: Remediation activities and other waste management services. Its registered office is in Temse. It employs on average 1,8 ETP workers (FTE).